Our white paper provides an overview of a comprehensive solution for generating Real World Evidence (RWE) in the field of precision oncology.
Oncology targeted therapies can significantly benefit from RWE programs, speeding up clinical development, supporting market access, and driving market penetration.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.
Flexible solutions. Responsive teams. Data-driven insights.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
